Similar Papers

Paper Title
Journal
Date
Author
Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients
Giorgio La Nasa ... Carlo Carcassi
Experimental Hematology | VOL. 41
Giorgio La Nasa, et. al.Giorgio La Nasa ... Carlo Carcassi
01 Feb 2013
Activation and Expansion of Natural Killer (NK) Cells with Potent Cytotoxicity for Multiple Myeloma
Jumei Shi ... Frits Van Rhee
Blood | VOL. 112
Jumei Shi, et. al.Jumei Shi ... Frits Van Rhee
16 Nov 2008
A View to Natural Killer Cells in Hepatitis C
Naglaa H Shoukry
Gastroenterology | VOL. 141
Naglaa H ShoukryNaglaa H Shoukry
27 Aug 2011
Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor–Negative Natural Killer Cells after NKG2A and LIR-1 Blockade
Robert Godal ... Jeffrey S Miller
Biology of Blood and Marrow Transplantation | VOL. 16
Robert Godal, et. al.Robert Godal ... Jeffrey S Miller
06 Feb 2010
View more papers

More From: British Journal of Haematology

Paper Title
Journal
Date
Author
Improvement in cutaneous disease with menin inhibitor monotherapy in KMT2A rearranged AML.
John Chadwick ... Emma Searle
British journal of haematology | VOL. -
John Chadwick, et. al.John Chadwick ... Emma Searle
30 Jan 2025
T-cell-based immunotherapies for human immunodeficiency virus patient with relapsed/refractory multiple myeloma: A success story from our clinic.
S Moraru ... Laure Ricard
British journal of haematology | VOL. -
S Moraru, et. al.S Moraru ... Laure Ricard
29 Jan 2025
First relapse in older adults with multiple myeloma: Creating new pathways in uncharted territory.
Tanya M Wildes
British journal of haematology | VOL. -
Tanya M WildesTanya M Wildes
27 Jan 2025
The ITP diagnostic challenge.
Tomás José González-López
British journal of haematology | VOL. -
Tomás José González-LópezTomás José González-López
27 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.